Efficacy and outcome analysis: monotherapy and combination therapy of S-1 for patients with advanced non-small cell lung cancer
Results indicated that both S-1 monotherapy and combination therapy showed promising efficacy and were well tolerated as second-line or later-line treatments for patients with advanced NSCLC. Further prospective studies are recommended to fully assess the therapeutic value of this treatment approach.
Authors
- Yao Zhou (ORCID: https://orcid.org/0000-0002-6527-9802)
- Ying Jin (ORCID: https://orcid.org/0000-0003-0840-773X)
- Wei Hong (ORCID: https://orcid.org/0000-0002-9236-9790)
- Feiyi Cao
- Wenjing Wang (ORCID: https://orcid.org/0000-0003-1087-0408)
- Cuiping Gu
Institutions
- Zhejiang Cancer Hospital (CN)
- Hangzhou Cancer Hospital (CN)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2024-10-01
- DOI
- https://doi.org/10.21037/jtd-24-940
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.42